Skip to main content
Commodore Capital logo

Commodore Capital

Healthcare Investment FirmNew York, United StatesSee on the mapcommodorecapital.com

Health specialist

biopharmaceuticalsgenetic medicinescellular therapies

Commodore Capital is an investment firm focused on biopharmaceutical companies developing medicines for patients.

2
Portfolio companies on reccy
1
Hiring now
12
Open roles in the portfolio
Jul 2026
Latest portfolio round

Hiring now in the portfolio12

See every role on each company's page

Portfolio on reccy2

Their companies, round by round

  • Alto NeuroscienceLos Altos, CA
    • Jul 2026Post-IPO Equity (PIPE) · $100MLed
    • Mar 2026Post-IPO Equity (PIPE) · $120MLed
    • Oct 2025Post-IPO Equity (PIPE) · $50MLed
    • Jul 2024Grant · $11.7M
    • Nov 2023Venture Round · $59.3M
    • Nov 2023Series C · $45M
  • LeonaBioBothell, Washington, United States
    • Dec 2025Post-IPO Equity · $90MLed
    • Jan 2021Post-IPO Equity · $104MLed
    • Dec 2020Grant · $15M
    • Sep 2020Convertible Note
    • Jun 2020Series B · $85M
    • Jun 2020Unknown · $90.9M

Rounds marked Led list Commodore Capital as a lead investor; the rest are the company's other funding.

Recent rounds in the portfolio